Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,855 | 2,594 | 1,783 | 6,708 | 3,763 |
| Receivables | N/A | N/A | N/A | N/A | 90 |
| TOTAL | $2,931 | $2,672 | $1,850 | $6,845 | $3,960 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,931 | $2,672 | $1,850 | $6,845 | $3,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,098 | 800 | 610 | 970 | 509 |
| Other current liabilities | 1 | 16 | 586 | 2,609 | N/A |
| TOTAL | $1,099 | $816 | $1,196 | $3,579 | $509 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 38 | 44 | 111 | 51 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,099 | $816 | $1,196 | $3,579 | $509 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,295 | 3,150 | 589 | 79 | 19 |
| Common Shares | N/A | N/A | 3 | N/A | N/A |
| Retained earnings | -105,489 | -102,580 | -90,928 | -80,551 | -76,999 |
| Other shareholders' equity | 0 | -941 | -928 | -639 | 0 |
| TOTAL | $1,832 | $1,856 | $654 | $3,266 | $3,451 |
| Total Liabilities And Equity | $2,931 | $2,672 | $1,850 | $6,845 | $3,960 |